Acuta Capital Partners as of June 30, 2017
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 55 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 14.4 | $51M | 365k | 140.92 | |
| SPDR S&P Biotech (XBI) | 8.3 | $30M | 382k | 77.18 | |
| Iovance Biotherapeutics (IOVA) | 7.7 | $28M | 3.7M | 7.35 | |
| Veracyte (VCYT) | 7.5 | $27M | 3.2M | 8.33 | |
| Ascendis Pharma A S (ASND) | 7.2 | $26M | 925k | 27.76 | |
| Assembly Biosciences | 7.0 | $25M | 1.2M | 20.65 | |
| IRIDEX Corporation (IRIX) | 4.8 | $17M | 1.7M | 9.89 | |
| Edge Therapeutics | 4.3 | $15M | 1.5M | 10.26 | |
| Immunomedics | 4.0 | $14M | 1.6M | 8.83 | |
| Nabriva Therapeutics | 2.8 | $9.9M | 946k | 10.48 | |
| Chembio Diagnostics | 2.3 | $8.2M | 1.4M | 6.05 | |
| Kite Pharma | 2.2 | $7.8M | 75k | 103.67 | |
| Evolent Health (EVH) | 2.0 | $7.1M | 281k | 25.35 | |
| Ra Pharmaceuticals | 2.0 | $7.0M | 374k | 18.74 | |
| ACADIA Pharmaceuticals (ACAD) | 1.9 | $7.0M | 250k | 27.89 | |
| Zogenix | 1.6 | $5.8M | 402k | 14.50 | |
| CAS Medical Systems | 1.6 | $5.5M | 4.8M | 1.16 | |
| Johnson & Johnson (JNJ) | 1.5 | $5.3M | 40k | 132.30 | |
| Viveve Med | 1.4 | $5.1M | 710k | 7.18 | |
| Viewray (VRAYQ) | 1.2 | $4.4M | 686k | 6.47 | |
| Quotient | 1.1 | $4.1M | 551k | 7.36 | |
| Anaptysbio Inc Common (ANAB) | 1.1 | $4.0M | 166k | 23.93 | |
| Dbv Technologies S A (DBVT) | 1.1 | $3.8M | 108k | 35.71 | |
| Tesaro | 0.9 | $3.3M | 24k | 139.87 | |
| Argenx Se (ARGX) | 0.9 | $3.2M | 153k | 21.21 | |
| Neuroderm Ltd F | 0.7 | $2.5M | 83k | 29.90 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $2.4M | 90k | 27.12 | |
| Juno Therapeutics | 0.7 | $2.4M | 80k | 29.89 | |
| Intec Pharma | 0.6 | $2.3M | 400k | 5.70 | |
| Aerie Pharmaceuticals | 0.6 | $2.1M | 40k | 52.55 | |
| WebMD Health | 0.5 | $1.9M | 33k | 58.64 | |
| Clovis Oncology | 0.5 | $1.9M | 20k | 93.65 | |
| Lannett Company | 0.5 | $1.8M | 90k | 20.40 | |
| Exelixis (EXEL) | 0.5 | $1.7M | 70k | 24.63 | |
| Spectranetics Corporation | 0.4 | $1.5M | 40k | 38.40 | |
| Recro Pharma (SCTL) | 0.4 | $1.4M | 201k | 7.03 | |
| Alimera Sciences | 0.4 | $1.4M | 974k | 1.39 | |
| Glaukos (GKOS) | 0.3 | $999k | 24k | 41.45 | |
| Invitae (NVTAQ) | 0.3 | $959k | 100k | 9.56 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $938k | 169k | 5.56 | |
| ZIOPHARM Oncology | 0.3 | $933k | 150k | 6.22 | |
| Insmed (INSM) | 0.2 | $858k | 50k | 17.16 | |
| Versartis | 0.2 | $857k | 49k | 17.45 | |
| Omeros Corporation (OMER) | 0.2 | $796k | 40k | 19.90 | |
| Acorda Therapeutics | 0.2 | $591k | 30k | 19.70 | |
| Gogo (GOGO) | 0.2 | $577k | 50k | 11.54 | |
| Myriad Genetics (MYGN) | 0.1 | $501k | 19k | 25.82 | |
| Cytokinetics (CYTK) | 0.1 | $484k | 40k | 12.10 | |
| ImmunoGen | 0.1 | $356k | 50k | 7.12 | |
| Sangamo Biosciences (SGMO) | 0.1 | $264k | 30k | 8.80 | |
| Essa Pharma | 0.1 | $243k | 442k | 0.55 | |
| Oncobiologics | 0.0 | $29k | 29k | 1.00 | |
| Mannkind (MNKD) | 0.0 | $46k | 32k | 1.42 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $17k | 97k | 0.18 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $8.7k | 97k | 0.09 |
